Drug Trial Radar · NCT04206605
A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)
Last checked: Nov 20, 2026Latest source record: Dec 27, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
77
Actual
Start
May 4, 2020
Primary completion
Oct 20, 2022
Study completion Oct 20, 2022
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- Collaborators
- Takeda Development Center Americas, Inc.
- First posted
- Dec 20, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main aim of this study is to check if repeated subcutaneous (SC) injections of lanadelumab can prevent angioedema attacks in teenagers and adults with non-histaminergic angioedema with normal C1-INH. Another aim is to check if they tolerate the repeated SC injections. Participants will receive a SC injection of lanadelumab every two weeks for 26 weeks. The first two doses of lanadelumab will be given at the study clinic. Once a participant (and/or parent/caregiver) has been appropriately trained, lanadelumab can be self-injected. Visits to the study clinic are planned for the first, third and fourth week and then every 4 weeks.
Conditions
- Angioedema
Interventions
PlaceboOther
Placebo-matching lanadelumab SC injection.
LanadelumabDrug
Lanadelumab solution in a PFS for injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Investigator-Confirmed Angioedema Attacks During the Treatment Period of Day 0 Through Day 182Time frame: Day 0 through Day 182
Locations
45 sites in 10 countries. Site status is shown where the registry gives one.
Clinical Research Center of Alabama
Birmingham, Alabama
Medical Research of Arizona
Scottsdale, Arizona
University of California San Diego
San Diego, California
AIRE Medical of Los Angeles
Santa Monica, California
Allergy and Asthma Clinical Research Inc
Walnut Creek, California
Asthma and Allergy Associates, PC
Colorado Springs, Colorado
University of South Florida Asthma, Allergy & Immunology
Tampa, Florida
Rush University Medical Center
Chicago, Illinois
Kanarek Allergy, Asthma and Immunology
Overland Park, Kansas
Institute for Asthma & Allergy - Chevy Chase
Chevy Chase, Maryland
Massachusetts General Hospital
Boston, Massachusetts
University of Michigan
Ann Arbor, Michigan
Mayo Clinic - Rochester
Rochester, Minnesota
Washington University
St Louis, Missouri
Jay M Kashkin, MD Allergy, Asthma and Immunology
Fair Lawn, New Jersey
Clinical Research of Charlotte
Charlotte, North Carolina
Bernstein Clinical Research Center, LLC
Cincinnati, Ohio
Optimed Research, LTD
Columbus, Ohio
Tanner Clinic
Layton, Utah
Seattle Allergy & Asthma Research Institute
Seattle, Washington
Ottawa Allergy Research Corporation
Ottawa, Ontario, Canada
Clinique Specialisee en Allergie de la Capitale
Québec, Quebec, Canada
CHU Grenoble Alpes, service de médecine interne, bureau de recherche clinique
Isere, France
Service médecine interne, hôpital Saint Antoine
Paris, France
Klinikum rechts der Isar der TUM, HNO Klinik und Poliklinik
Munich, Germany
Klinikum der Johann Wolfgang Goethe-Universitaet
Frankfurt am Main, Hesse, Germany
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz
Mainz, Rhineland-Palatinate, Germany
Universitaetsklinikum Leipzig AoeR
Leipzig, Saxony, Germany
Semmelweis Egyetem
Budapest, Hungary
Azienda Socio Sanitaria Territoriale Fatebenefratelli (Presidio Ospedale Sacco)
Milan, Italy
DAI di Medicina Interna, Immunologia Clinica, Patologia Clinica, Malattie Infettive
Naples, Italy
Azienda Ospedaliera Universitaria OO. RR. S. Giovanni di Dio e Ruggi D'Aragona
Salerno, Italy
Hiroshima University Hospital
Hiroshima, Japan
Kobe University Hospital
Hyōgo, Japan
Amsterdam UMC
Amsterdam, Netherlands
Universitair Medisch Centrum Groningen
Groningen, Netherlands
UMC Utrecht
Utrecht, Netherlands
NZOZ Homeo Medicus, Poradnia Alergologiczna
Bialystok, Poland
"ALL-MED" Specjalistyczna Opieka Medyczna Medyczny Instytut Badawczy
Wroclaw, Poland
Hospital Universitari Vall d'Hebron
Barcelona, Spain
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.